SCHEMBL14923504

SCHEMBL14923504

CC(C)(C)OC(=O)NCCN(C(=O)OC(C)(C)C)c1nc(Cl)c(C#N)cc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.36
STK17B O94768 1/20 0.35
STK17A Q9UEE5 1/20 0.35
KHK P50053 1/20 0.35
CKS1B P61024 1/20 0.35
SKP1 P63208 1/20 0.35
SKP2 Q13309 1/20 0.35
SUV39H2 Q9H5I1 1/20 0.34
PARP1 P09874 1/20 0.34
BCHE P06276 1/20 0.33
NQO2 P16083 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
GLA P06280 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
XBP1 P17861 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14909824 0.92 KHK (0.35) TRPA1KHKALDH1A1GLANPSR1
SCHEMBL14927570 0.87 KHK (0.39) TRPA1KHKALDH1A1GLAMAPT
SCHEMBL14923933 0.86 KHK (0.38) TRPA1KHKALDH1A1GLAGPR119
SCHEMBL14911315 0.84 KEAP1 (0.40) STK17BSTK17ACKS1BSKP1SKP2
SCHEMBL14909095 0.83 ATR (0.38) STK17BSTK17ACKS1BSKP1SKP2
SCHEMBL14931090 0.83 GRM2 (0.36) STK17BSTK17ACKS1BSKP1SKP2
SCHEMBL3388507 0.79 STK17B (0.45) TRPA1STK17BSTK17AKHKBCHE
SCHEMBL3387122 0.76 SYK (0.36) TRPA1KHKCTSSCTSKAAK1
SCHEMBL14909331 0.75 CD38 (0.32) ALDH1A1
SCHEMBL14909827 0.74 KHK (0.36) TRPA1KHKALDH1A1GLAGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK TRPA1 1310/4885STK17B 870/4885STK17A 924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.